Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experience

• Những tác giả chính: Malak Moubarak (Tác giả), Philipp Harter (Tác giả), Beyhan Ataseven (Tác giả), Alexander Traut (Tác giả), Julia Welz (Tác giả), Thais Baert (Tác giả), Florian Heitz (Tác giả)
• Định dạng: Sách
• Được phát hành: Elsevier, 2022-04-01T00:00:00Z.
• Những chủ đề: article
• Truy cập trực tuyến: Connect to this object online.

Introduction: We aimed to evaluate real-life experiences with the re-challenge of poly(ADP-Ribose)Polymerase (PARP) inhibitors (PARPi) after a prior PARPi therapy in patients with recurrent EOC. Methods: A retrospective descriptive study was conducted at a tertiary care center of excellence for ovar...